https://ibdnewstoday.com/2019/05/14/panaxia-and-rafa-sign-a-collaboration-agreement-with-plantext-to-research-and-manufacture-the-first-medical-cannabis-suppositories-int
'Two Israeli pharmaceutical companies are collaborating with a medical cannabis company to develop what’s being touted as the first medical cannabis rectal suppositories specifically targeted to inflammatory bowel disease (IBD) patients. Panaxia Pharmaceutical Industries and Rafa have signed a partnership pact with PlantEXT, an Israeli-Canadian medical cannabis company, to co-develop the products.'
Sounds interesting